(R)-N-(2-((1-benzylpyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide, 98%, 1g

5-Bromoindazole>97.0%(GC)1g

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride, 95+%, 250mg

4-(2,4-Difluorobenzyl)piperidine, 95+%, 1g

3-METHOXY-2-METHYLPYRIDINE, 95.0%, 1g

2-(2-Naphthyloxy)propanohydrazide, 95.0%, 1g

3-(FURAN-2-YL)ISOXAZOL-5-AMINE, 95.0%, 250mg

5-chloro-1-(4-methoxyphenyl)-3-(propan-2-yl)-1H-pyrazole-4-carbaldehyde, 95.0%, 2g

4-Bromo-1-ethyl-2-fluorobenzene, 95.0%, 1g

D-Luciferin, 95%, 5g

(S)-Ethyl 2-((tert-butyldimethylsilyl)oxy)propanoate, 95.0%, 25g

5'-(3,5-Dicarboxyphenyl)-2',4',6'-trimethyl-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid, 98%, 1g

ROTI®Prep gDNA Mini 2.0, 50 preparations